T2 Biosystems
Stock Forecast, Prediction & Price Target
T2 Biosystems Financial Estimates
T2 Biosystems Revenue Estimates
T2 Biosystems EBITDA Estimates
T2 Biosystems Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $28.05M N/A | $22.30M -20.50% | $7.19M -67.75% | Avg: $23.1M Low: $23.1M High: $23.1M avg. 221.14% | Avg: $33.7M Low: $33.7M High: $33.7M avg. 45.88% | Avg: $46.2M Low: $46.2M High: $46.2M avg. 37.09% | Avg: $61M Low: $61M High: $61M avg. 32.03% |
Net Income
% change YoY
| $-53.49M N/A | $-63.37M -18.45% | $-50.07M 20.97% | Avg: $-47.7M Low: $-3.65M High: $-3.65M avg. 4.74% | Avg: $-46.5M Low: $-2.16M High: $-2.16M avg. 2.51% | Avg: $-1.46M Low: $-1.46M High: $-1.46M avg. 96.85% | Avg: $-965.69K Low: $-965.69K High: $-965.69K avg. 33.92% |
EBITDA
% change YoY
| $-42.65M N/A | $-55.47M -30.04% | $-43.87M 20.90% | Avg: $-23.1M Low: $-23.1M High: $-23.1M avg. 47.35% | Avg: $-33.7M Low: $-33.7M High: $-33.7M avg. -45.88% | Avg: $-46.2M Low: $-46.2M High: $-46.2M avg. -37.09% | Avg: $-61M Low: $-61M High: $-61M avg. -32.03% |
EPS
% change YoY
| -$1,683.72 N/A | -$1,242.48 26.20% | -$19.19 98.45% | Avg: -$1.4 Low: -$1.4 High: -$1.4 avg. 92.70% | Avg: -$0.83 Low: -$0.83 High: -$0.83 avg. 40.71% | Avg: -$0.56 Low: -$0.56 High: -$0.56 avg. 32.53% | Avg: -$0.37 Low: -$0.37 High: -$0.37 avg. 33.92% |
Operating Expenses
% change YoY
| $50.32M N/A | $56.67M 12.61% | $41.49M -26.78% | Avg: $47.57M Low: $47.57M High: $47.57M avg. 14.64% | Avg: $69.40M Low: $69.40M High: $69.40M avg. 45.88% | Avg: $95.14M Low: $95.14M High: $95.14M avg. 37.09% | Avg: $125.62M Low: $125.62M High: $125.62M avg. 32.03% |
FAQ
What is T2 Biosystems stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 34.51% in 2025-2028.
We have gathered data from 1 analysts. Their low estimate is -3.65M, average is -47.7M and high is -3.65M.
What is T2 Biosystems stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 84.03% in 2025-2028.
We have gathered data from 1 analysts. Their low revenue estimate is $23.1M, average is $23.1M and high is $23.1M.
What is T2 Biosystems stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 49.96% in 2025-2028.
We have gathered data from 1 analysts. Their low earnings per share estimate is -$1.4, average is -$1.4 and high is $-1.4.